Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
about
Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy.In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.PET imaging biomarkers in head and neck cancer.Long-term outcome of (18) F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting.Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy.Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods.The promise of multiparametric imaging in oncology: how do we move forward?Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer.The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis.High-dose-rate brachytherapy in severe trismus: Making it happen!
P2860
Q33726601-34449751-CE62-429C-B6EE-957E455D0EC3Q33798433-35DB43C8-5260-41BC-A0CA-F8DF1476634EQ35830998-9DC3A00B-299A-44AB-B399-B26EABEE4B39Q36300626-346F3ECE-3352-44A6-80E0-56968F88D866Q37581964-67116731-B720-42F6-AAA4-9595D944A156Q38312362-31147C29-15A7-4390-A796-C6686C14B5ACQ38398891-45912E35-79BF-4C5C-979B-8A141B8A52BDQ38412352-7AE56584-AB6A-4FB1-944A-BEB28DC6EE68Q38412675-8EA58BF6-3B3A-4180-BE6C-F09731A87E6FQ38413433-AAAC1894-2959-4D0E-B912-6C64999E8549Q38414202-582391FB-0E40-4EF6-92E5-C7673B91C3F8Q40704410-B1D7857C-44C9-42CC-B584-A0A64CB4A5B3Q47692533-9F22AF07-6C71-40A1-83F4-BDB91BCC34FDQ50084052-E498AAFC-B110-4CC3-B82A-BC40C298A9CBQ50499349-423FB1D0-8E9B-4957-B1C9-124A3128C0BEQ50525080-AA290777-E72F-48F6-ABCC-6DE29C55BB04Q50575883-E425EE02-E9BC-437E-BD11-8DFB9463F2ADQ51814005-E7FB65C3-EEFA-4EC7-A2D3-624AB54CCD1EQ52990736-53315C4C-9770-4D87-B67D-BEEA3BD27315Q55215317-AA6051FA-688A-4A28-A0C2-85FFFDBE4618Q55398529-2871241B-8D3B-4378-9C50-8A2F4AE0D587Q58779750-236C7B1A-F962-400B-997B-D942E133223C
P2860
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@ast
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@en
type
label
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@ast
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@en
prefLabel
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@ast
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@en
P2093
P2860
P50
P1476
Recurrences after intensity mo ...... high baseline [18F]-FDG uptake
@en
P2093
Anne K Berthelsen
Anne K Due
Annika Loft
Claus A Kristensen
Marianne C Aznar
P2860
P304
P356
10.1016/J.RADONC.2014.06.001
P577
2014-06-30T00:00:00Z